Cambridge Medicine Mental Health Books 2014

M e n ta l H e a lt h Books 2014

This catalogue contains a selection of our most recent publishing in this area. Please visit our website for a full and searchable listing of all our titles in print and also an extensive range of news, features and resources. Our online ordering service is secure and easy to use.

Cambridge University Press advances learning, knowledge and research worldwide.

Useful contacts Further information about Medicine titles: telephone +44 (0) 1223 326050 or email information@cambridge.org Prices and publication dates are correct at the time of going to press but are subject to alteration without notice.

Order online now at www.cambridge.org/mentalhealth General enquiries: +44 (0)1223 326050 When purchasing, please quote the product ISBNs. For information about our privacy and data protection policy, please visit www.cambridge.org/privacy or email mlist@cambridge.org

3 Highlight

Highlight

Stahl’s Essential Psychopharmacology

Stahl’s Illustrated Substance Use and Impulsive Disorders

Neuroscientific Basis and Practical Applications Fourth edition Stephen M. Stahl University of California, San Diego

This fully revised edition returns to the essential roots of what it means to become a neurobiologically empowered psychopharmacologist, expertly guided in the selection of treatments for individual patients. This remains the essential text for all students and professionals in mental health seeking to understand and utilize current therapeutics.

Contents: Preface to the fourth edition; CME information; 1. Chemical neurotransmission; 2. Transporters, receptors and enzymes as targets of psychopharmacological drug action; 3. Ion channels as targets of psychopharmacological drug action; 4. Psychosis and schizophrenia; 5. Antipsychotic agents; 6. Mood disorders; 7. Antidepressants; 8. Mood stabilizers; 9. Anxiety disorders and anxiolytics; 10. Chronic pain and its treatment; 11. Disorders of sleep and wakefulness and their treatment; 12. Attention deficit hyperactivity disorder and its treatment; 13. Dementia and its treatment; 14. Impulsivity, compulsivity and addiction; Suggested reading and selected references; Index.

Review of previous edition: ‘… essential reading … I would thoroughly recommend this book to anyone who works with psychotropic drugs – or who has the task of teaching others about them!’

American Journal of Psychiatry

Stephen M. Stahl University of California, San Diego

and Meghan M. Grady Neuroscience Education Institute

The pocket-sized, themed volumes in the Stahl’s Illustrated series combine theoretical information from Stahl’s Essential Psychopharmacology with practical data from The Prescriber’s Guide. Visual learners will find that these books make the concepts easier to master, and non-visual learners will appreciate the clear, shortened text on complex psychopharmacological concepts.

Contents: Preface; CME information; Objectives; 1. Substance use and addiction: an overview; 2. The neurobiology of reward and drug addiction; 3. Alcohol; 4. Opioids; 5. Nicotine; 6. Stimulants; 7. Marijuana; 8. Other drugs of abuse; 9. Psychosocial treatment for substance use disorders; 10. Disorders of impulsivity and compulsivity; Summary; Abbreviations; References; Index; CME: posttest and certificate.

Stahl’s Illustrated

2012 210 x 149 mm 183pp 100 colour illus. 13 tables 978-1-107-67453-0 Paperback £31.99 For all formats available, see

www.cambridge.org/9781107674530

2013 246 x 189 mm 628pp 588 colour illus. 57 tables 978-1-107-02598-1 Hardback £120.00 978-1-107-68646-5 Paperback £65.00 For all formats available, see

www.cambridge.org/9781107025981

eBooks available at www.cambridge.org/ebookstore

4 Highlight

Highlight

Mood Disorders and Antidepressants

Print/online bundle

Stahl’s Essential Psychopharmacology Fourth edition Stephen M. Stahl University of California, San Diego

With the fully revised fourth edition of Essential Psychopharmacology, Dr Stahl returns to the essential roots of what it means to become a neurobiologically empowered psychopharmacologist. This special edition, featuring the extracted chapters on mood disorders and antidepressants, provides a readable digest on these issues for experts and novices alike.

Contents: Preface; 6. Mood disorders; 7. Antidepressants; Index.

2013 246 x 189 mm 148pp 978-1-107-64267-6 Paperback £29.99 For all formats available, see

www.cambridge.org/9781107642676

Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practical Applications Fourth edition Stephen M. Stahl University of California, San Diego

This is a product combining the fourth edition of Dr Stahl’s market-leading psychopharmacology textbook with a one-year subscription to www. stahlonline.org providing access to the full range of other Stahl content.

Contents: Preface to the fourth edition; CME information; 1. Chemical neurotransmission; 2. Transporters, receptors and enzymes as targets of psychopharmacological drug action; 3. Ion channels as targets of psychopharmacological drug action; 4. Psychosis and schizophrenia; 5. Antipsychotic agents; 6. Mood disorders; 7. Antidepressants; 8. Mood stabilizers; 9. Anxiety disorders and anxiolytics; 10. Chronic pain and its treatment; 11. Disorders of sleep and wakefulness and their treatment; 12. Attention deficit hyperactivity disorder and its treatment; 13. Dementia and its treatment; 14. Impulsivity, compulsivity and addiction; Suggested reading and selected references; Index.

2014 246 x 189 mm 620pp 978-1-107-58767-0 Print and Online Bundle £190.00 For all formats available, see

www.cambridge.org/9781107587670

5 Highlight

The Prescriber’s Guide Stahl’s Essential Psychopharmacology Fifth edition Stephen M. Stahl University of California, San Diego

With coverage of 16 brand-new drugs – including six fresh-to-market critical new compounds – and incorporating the latest information on new indications, new formulations, new recommendations and new safety data, the fifth edition of this indispensable guide provides the essential practical support required by anyone prescribing in the field of mental health.

Contents: 1. Acamprosate; 2. Agomelatine; 3. Alprazolam; 4. Amisulpride; 5. Amitriptyline; 6. Amoxapine; 7. Amphetamine (d); 8. Amphetamine (d,l); 9. Aripiprazole; 10. Armadafinil; 11. Asenapine; 12. Atomoxetine; 13. Benztropine; 14. Blonanserin; 15. Buprenorphine; 16. Bupropion; 17. Buspirone; 18. Caprylidene; 19. Carbamazepine; 20. Chlordiazepoxide; 21. Chlorpromazine; 22. Citalopram; 23. Clomipramine; 24. Clonazepam; 25. Clonidine; 26. Clorazepate; 27. Clozapine; 28. Cyamemazine; 29. Desipramine; 30. Desvenlafaxine; 31. Dextromethorphan; 32. Diazepam; 33. Diphenhydramine; 34. Disulfiram; 35. Donepezil; 36. Dothiepin; 37. Doxepin; 38. Duloxetine; 39. Escitalopram; 40. Estazolam; 41. Eszopiclone; 42. Flumazenil; 43. Flunitrazepam; 44. Fluoxetine; 45. Fluphenthixol; 46. Fluphenazine; 47. Flurazepam; 48. Fluvoxamine; 49. Gabapentin; 50. Galantamine; 51. Guanfacine; 52. Haloperidol; 53. Hydroxyzine; 54. I-methylfolate; 55. Iloperidone; 56. Imipramine; 57. Isocarboxazid; 58. Ketamine; 59. Lamotrigine; 60. Levetiracetam; 61. Levomilnacipran; 62. Lisdexamfetamine; 63. Lithium; 64. Lorcaserin; 65. Lofepramine; 66. Loflazeptate; 67. Lorazepam; 68. Loxapine; 69. Lurasidone; 70. Mainserin;

71. Maprotiline; 72. Memantine; 73. Mesoridazine; 74. Methylphenidate (d); 75. Midazolam; 76. Milnacipran; 77. Mirtazapine; 78. Moclobemide; 79. Modafinil; 80. Molindone; 81. Nalmefene; 82. Naltrexone; 83. Nefazodone; 84. Nortriptyline; 85. Olanzapine; 86. Oxazepam; 87. Oxcarbazepine; 88. Paliperidone; 89. Paroxetine; 90. Perospirone; 91. Perphenazine; 92. Phenelzine; 93. Phenterminetopiramate; 94. Pimozide; 95. Pipothiazine; 96. Prazosin; 97. Pregabalin; 98. Propranolol; 99. Protriptyline; 100. Quazepam; 101. Quetiapine; 102. Ramelteon; 103. Reboxetine; 104. Risperidone; 105. Rivastigmine; 106. Selegiline; 107. Sertindole; 108. Sertraline; 109. Sodium Oxybate; 110. Sulpiride; 111. Temazepam; 112. Thioridazine; 113. Thiothixene; 114. Tiagabine; 115. Tianeptine; 116. Trihexyphenidyl; 117. Triiodothyronine; 118. Topiramate; 119. Tranylcypromide; 120. Trazodone; 121. Triazolam; 122. Trifluoperazine; 123. Trimipramine; 124. Valproate; 125. Varenicline; 126. Venlafaxine; 127. Vortioxetine; 128. Zalepron; 129. Ziprasidone; 130. Zolpidem; 131. Zonisamide; 132. Zopiclone; 133. Zotepine; 134. Zuclopenthixol.

Review of previous edition: ‘This manual has all the characteristics of a true bestseller. The format is very attractive, the information is complete, the consultation is easy. In no other recent text will a clinician find so much information in such a concise and userfriendly format.’

Acta Psychiatrica Scandinavica 2014 228 x 138 mm 725pp 2 b/w illus.

978-1-107-67502-5 Paperback c. £55.00 Publication May 2014 For all formats available, see

www.cambridge.org/9781107675025

For regular email alerts visit www.cambridge.org/alerts

6 A Concise Guide to Understanding Suicide Epidemiology, Pathophysiology and Prevention Edited by Stephen H. Koslow University of Miami

Pedro Ruiz University of Miami

and Charles B. Nemeroff University of Miami

Leading researchers summarize research on understanding, treating and preventing suicide and provide practical information for educating practising clinicians, health care workers and researchers and a pathway for undergraduate and graduate students interested in solutions to suicide.

It will also appeal to the University community and lay public nationally and internationally.

Contents: Introduction: looking to the future – how can research prevent suicide?; Part I. Understanding Suicide: 1. Brief history of suicide in Western cultures; 2. Global epidemiology of suicide; 3. Identification and screening of suicide risk; 4. Rethinking suicide risk assessment and risk formulation; 5. High risk cognitive states; 6. Suicide clusters and suicide contagion; 7. Ethnicity: how much of our understanding of suicide is applicable across ethnic cultures?; 8. Suicide-related bereavement and grief; 9. Statistics; Part II. Suicidal Comorbidities: 10. Current and chronic signs and symptoms; 11. Anxiety, depression and suicide: epidemiology, pathophysiology and prevention; 12. Suicide in schizophrenia; 13. Personality disorders and suicide; 14. Suicide and substance use disorders; 15. Eating disorders and suicide; 16. Suicidality and epilepsy: a complex relationship; Part III. Special Populations: 17. Suicidal ideation and behavior during pregnancy and the postpartum period; 18. Childhood and adolescence; 19. Indigenous/native populations; 20. Bullying and suicidality in youth; 21. College students; 22. Suicide in

older adults; 23. Armed forces; 24. Medical illness; 25. Suicide in the criminal justice system; Part IV. Treatment: 26. Reduction of suicidal behavior in bipolar disorder patients during long-term treatment with lithium; 27. Clozapine; 28. Antidepressants; 29. Suicide and emergency room treatment; 30. Psychosocial approaches to reduce suicidal behavior; Part V. Research: Mediators and Moderators: 31. Genome-wide association studies of suicidal behaviors; 32. Epigenetics; 33. The use of neuroimaging to investigate the pathophysiology of suicide; 34. Brain serotonin in suicides with psychological autopsy; 35. The noradrenergic system in depression and suicide; 36. Brain CRF and the HPA axis in suicide; 37. Receptor signaling in suicide; Part VI. Suicide Prevention: 38. Strategies to improve suicide prevention; 39. Safety planning to prevent suicidal behavior; 40. Contracting for safety; 41. Suicide and the media; Index.

2014 246 x 189 mm 400pp 28 b/w illus. 8 colour illus. 20 tables 978-1-107-03323-8 Hardback £75.00 Publication June 2014 For all formats available, see

www.cambridge.org/9781107033238

7 Essentials of Global Mental Health Edited by Samuel O. Okpaku Center for Health, Culture, and Society, Nashville

Defines an approach to mental healthcare focused on the provision of evidence-based, cost-effective treatments, founded on the principles of sharing the best information about common problems and achieving international equity in coverage, options and outcomes.

Contents: Preface; Introduction; Part I. History and Background to Global Mental Health: 1. History of global mental health; 2. Burden of illness; 3. Trends and gaps in mental health disparities; 4. Global health and mental health as diplomacy; 5. Global mental health and the United Nations; Part II. Advocacy and Reduction of Stigma: 6. Voice of user survivor; 7. Lecture on internalized stigma; 8. Definition and process of stigma; 9. Stigmatization and exclusion; 10. Grassroots mental health movements; 11. The rise of consumerism and local advocacy; 12. Programs to reduce stigma in HIV/AIDS, mental illness and epilepsy; Part III. Systems of Development: 13. The challenges of human resources in low and middle income countries; 14. Integration of mental health services in primary care settings; 15. Collaboration between traditional and Western practitioners; 16. Setting up an integrated mental health system; Part IV. Systems of Development for Special Populations: 17. Poverty and perinatal morbidity as risk factors for mental illness; 18. Maternal mental health care: refining the components in a South African setting; 19. Screening for developmental disabilities in epidemiologic studies in low and middle income countries; 20. Child services; 21. Child abuse as a global mental health problem; 22. Child soldiers; 23. Mental health and intellectual disability: implications for global mental health; 24. Adolescent alcohol and substance abuse; 25. Developing intervention in low resource contexts; Part V. Gender and Equality: 26. Strategies to reduce women’s

mental illness and increase attention to women’s mental health; 27. Violence against women; 28. Women and global mental health: vulnerability and empowerment; 29. Trafficking in persons; Part VI. Human Resources and Capacity Building: 30. Capacity building; 31. Use of allied professionals; 32. Mental health and illness in conflict areas; 33. Implications of disasters for global mental health; 34. International response to natural and manmade disasters; 35. Global health governance and international law, and mental health; 36. The role of NGOs; 37. Mental health, mass communication and media; Part VII. Suicide and Violence: 38. Suicide and depression; 39. Violence as a public health problem; 40. Setting up integrated mental health systems: the case of Cuba; 41. The war on drugs – the US, Mexico and Central American countries and Plan Colombia and Merida; Part VIII. Research and Monitoring Progress of Countries: 42. Medical education and global mental health; 43. Research priorities for mental health in low and middle income countries (LMIC); 44. Research infrastructure; 45. Monitoring progress of countries; Epilogue; Index.

2014 246 x 189 mm 468pp 26 b/w illus. 37 tables 978-1-107-02232-4 Hardback Publication February 2014

£85.00

For all formats available, see

www.cambridge.org/9781107022324

Visit our website at www.cambridge.org/knowledge

8 Health Inequalities and People with Intellectual Disabilities Eric Emerson University of Sydney and Lancaster University

and Chris Hatton Lancaster University

People with intellectual disabilities die younger and have poorer health than their peers. This book provides an authoritative, evidence-based overview of why this happens and what needs to be done. It is an invaluable resource for practitioners, advocates, policymakers and researchers concerned with the health and wellbeing of disabled people.

Contents: Preface; 1. People with intellectual disabilities; 2. Health and health inequalities; 3. The health of people with intellectual disabilities; 4. Applying a health inequalities perspective; 5. Addressing the health inequalities faced by people with intellectual disabilities; 6. Conclusions; References; Index.

2013 234 x 156 mm 173pp 15 b/w illus. 5 tables 978-0-521-13314-2 Paperback £35.00 For all formats available, see

www.cambridge.org/9780521133142

Mental Health and Poverty Rob Poole Glyndwr University

Robert Higgo Bangor University

and Catherine A. Robinson Bangor University

Poverty is not inevitable, even in a difficult economic climate, and there is strong scientific evidence that poverty is a cause of mental illness. This book brings together a body of knowledge from biomedical and social science literature, providing an evidence-based resource for mental health professionals, social scientists and their students.

Contents: Preface; 1. Severe mental illness and social factors; 2. Poverty; 3. Constellations of disadvantage; 4. Depression and anxiety; 5. Genetics; 6. Substance misuse; 7. Mechanisms; 8. Stigma; 9. Recovery; 10. Working with poverty; 11. Afterword; References; Index.

2013 234 x 156 mm 192pp 978-0-521-14396-7 Hardback

£55.00

For all formats available, see

www.cambridge.org/9780521143967

9 Schizo-Obsessive Disorder Michael Poyurovsky Tirat Carmel Mental Health Center, Israel

This is the first book to address the clinical and neurobiological interface between schizophrenia and obsessivecompulsive disorder (OCD). It uses numerous case studies to present diagnostic guidelines and to describe a recommended treatment algorithm, demystifying this complex disorder and aiding its effective management.

Contents: Foreword; Preface; 1. Schizophrenia and OCD: comparative characteristics; 2. Obsessive-compulsive symptoms in schizophrenia: conceptual history; 3. Obsessive-compulsive symptoms in schizophrenia: epidemiological and clinical aspects; 4. Obsessive-compulsive symptoms in schizophrenia: psychopathological characteristics; 5. Obsessive-compulsive symptoms in schizophrenia: prodrome; 6. Obsessive-compulsive symptoms in schizophrenia: across life span; 7. OCDspectrum disorders in schizophrenia; 8. Schizotypal OCD; 9. OCD with poor insight; 10. Neurobiology of schizo-obsessive disorder; 11. Treatment of schizophrenia with obsessivecompulsive symptoms; 12. Antipsychotic drug-induced obsessive-compulsive symptoms; 13. Conclusions and future directions; Index.

2013 234 x 156 mm 245pp 11 b/w illus. 40 tables 978-1-107-00012-4 Hardback

The Maudsley Reader in Phenomenological Psychiatry Edited by Matthew R. Broome University of Warwick

Robert Harland South London and Maudsley NHS Foundation Trust

Gareth S. Owen Institute of Psychiatry, London

and Argyris Stringaris Institute of Psychiatry, London

This unique book brings together and interprets previously hard-to-find texts, new translations and passages detailing the interplay between philosophy and psychopathology, making them accessible to a new generation of mental health researchers, practitioners and policy makers.

Contents: Part I. Intellectual Background; Part II. The Phenomenological Approach in Psychiatry; Part III. Phenomenologies of Mental Disorder.

‘[The Reader] brings together texts from both philosophers and clinicians which are otherwise difficult to access; many are newly translated … I found it absorbing and illuminating.’

Baroness Mary Warnock, House of Lords

For all formats available, see

2013 246 x 189 mm 295pp 978-0-521-88275-0 Hardback £80.00 978-0-521-70927-9 Paperback £40.00

www.cambridge.org/9781107000124

For all formats available, see

£65.00

www.cambridge.org/9780521882750

eBooks available at www.cambridge.org/ebookstore

10 Behavioral Neurology & Neuropsychiatry Edited by David B. Arciniegas University of Colorado, School of Medicine

C. Alan Anderson University of Colorado, School of Medicine

and Christopher M. Filley University of Colorado, School of Medicine

This is the only textbook designed specifically for trainees and practitioners in behavioral neurology and neuropsychiatry, a developing medical subspecialty. The principles of clinical neuroanatomy, neuropsychiatric assessment and treatment described by internationally renowned contributors prepare clinicians for work with patients affected by neuropsychiatric and neurological conditions.

Contents: Preface; Foreword; 1. Introduction; Part I. Structural and Functional Neuroanatomy: 2. Behavioral neuroanatomy: brainstem, subcortical structures, limbic system, and cerebral cortex and supporting structures; 3. Cerebellum; 4. White matter; 5. Frontal-subcortical circuits; 6. Arousal; 7. Sleep; 8. Attention; 9. Motivation; 10. Perception and recognition; 11. Memory; 12. Language; 13. Prosody; 14. Praxis; 15. Visuospatial function; 16. Executive function; 17. Comportment; 18. Emotion; 19. Personality; Part II. Neurobehavioral and Neuropsychiatric Assessment: 20. Neuropsychiatric evaluation; 21. Neurological examination; 22. Assessment for subtle neurological signs; 23. Mental status examination; 24. Neuropsychological assessment; 25. Forensic assessment; 26. Structural neuroimaging; 27. Advanced neuroimaging; 28. Electroencephalography;

29. Advanced electrophysiology; 30. Neurotoxicology; 31. Neuropathological assessment; Part III. Treatments in Behavioral Neurology and Neuropsychiatry: 32. Principles of pharmacotherapy; 33. Rehabilitation and pharmacotherapy of cognitive impairment; 34. Pharmacotherapy of emotional disturbances; 35. Pharmacotherapy of behavioral disturbances; 36. Psychotherapy; 37. Environmental and behavioral interventions; 38. Procedural interventions; Index.

2013 246 x 189 mm 681pp 127 b/w illus. 43 colour illus.

978-0-521-87501-1 Hardback

£90.00

For all formats available, see

www.cambridge.org/9780521875011

11 Cognitive Impairment in Schizophrenia Characteristics, Assessment and Treatment Edited by Philip D. Harvey University of Miami

This book presents state-of-the-art understanding of the most important features of severe mental illness: cognition and disability. Written in an accessible, informative style by leading experts, this is essential reading for researchers and clinicians working with patients impaired by severe mental illness.

defects; Part IV. Assessment and Treatment of Cognitive Impairment and Related Features: 13. Assessment of cognition in schizophrenia treatment; 14. Performance-based measures of functioning in schizophrenia; 15. Pharmacological approaches to cognitive enhancement; 16. Computerized cognitive training in schizophrenia: current knowledge and future directions; Index.

2013 234 x 156 mm 328pp 34 b/w illus. 7 colour illus.

978-1-107-01320-9 Hardback

£60.00

For all formats available, see

www.cambridge.org/9781107013209

Contents: Preface; Part I. Characteristics of Cognitive Impairment in Schizophrenia: 1. Cognition in schizophrenia as a central illness feature; 2. The multi-faceted, ‘global’ cognitive impairment profile in schizophrenia; 3. Comparative impairments across schizophrenia and bipolar disorder; 4. Cognitive impairment and symptom dimensions in psychosis; Part II. Functional Implications and Course: 5. Neurocognition and functional outcome in schizophrenia: filling in the gaps; 6. Cognition and work functioning in schizophrenia; 7. Cognition and functional status in adult and older patients with schizophrenia; 8. Social cognition and its relationship to neurocognition; 9. Cognitive functioning and awareness of illness in schizophrenia: a review and metaanalysis; Part III. Genetic and Biological Contributions to Cognitive Impairment: 10. Genetic influences on cognition in schizophrenia; 11. Neurobiological determinants of cognition; 12. Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches towards understanding cognitive

Visit our website at www.cambridge.org/knowledge

12 Cognitive Behaviour Therapy for Children and Families Third edition Edited by Philip Graham Institute of Child Health

and Shirley Reynolds University of Reading

This is the third edition of a comprehensive, authoritative text covering the cognitive behaviour therapy interventions for all conditions seen in children and adolescents. The international panel of contributors ensures the highly authoritative and relevant nature of the content, making this text an invaluable source for all child and adolescent mental health professionals.

Contents: Preface; 1. Introduction; Part I. Developmental Cognitive Theory and Clinical Practice: 2. Anxiety and depression in young people: developmental considerations; 3. Adapting cognitive and behavioural therapy for children and adolescents; 4. Issues in evaluation of psychotherapies; Part II. Engagement and Assessment: 5. Engagement; 6. Formulation: a systematic approach in cognitive behaviour therapy; Part III. Client Groups: 7. Working collaboratively with parents and carers in cognitive behaviour therapy; 8. Working with black and ethnic minority children and their families; 9. Working with schools and children’s wider social environment; Part IV. Cognitive Approaches to Children Facing Adversity: 10. Trauma-focused cognitive behavioural therapy for child sexual abuse; 11. Children with chronic and life-limiting health problems; 12. Cognitive approaches to children with chronic pain; Part V. Applications in Specific Child and Adolescent Syndromes: 13. Cognitive behavioural therapies for youth with autistic spectrum disorders; 14. Eating disorders; 15. Treating broad-based anxiety problems in children; 16. Post-traumatic stress disorders; 17. Phobic anxiety; 18. Obsessive compulsive disorder; 19. Depressive disorders;

Part VI. CBT Applications in Preventive Interventions: 20. Prevention of conduct disorders: cognitive behavioural approaches; 21. Prevention of anxiety disorders; Part VII. New Developments in CBT for Children: 22. Using low intensity treatment methods with families; 23. Using new technologies to deliver cognitive behaviour therapy with children and adolescents; 24. Mindfulness interventions in child and adolescent psychopathology; 25. Conclusions and future directions; Index.

Review of previous edition: ‘I really do like the balance of theory, evidence for theory and practice, practice tips and worked examples showing how to apply the treatment in real life … I highly recommend this book, to any student, be they new to the field or experienced practitioners of child and adolescent mental health who want a grasp of contemporary CBT in CAMHS.’ Psychological Medicine Cambridge Child and Adolescent Psychiatry

2013 247 x 174 mm 411pp 30 b/w illus. 9 tables 978-1-107-68985-5 Paperback £52.00 For all formats available, see

www.cambridge.org/9781107689855

13 Emergency Psychiatry Arjun Chanmugam Johns Hopkins Medical Institutions

Global Perspectives from the WHO World Mental Health Surveys Edited by Jordi Alonso

Patrick Triplett Johns Hopkins Medical Institutions

and Gabor Kelen The Johns Hopkins University

Providers in primary care, emergency care or other acute care environments encounter patients with psychiatric problems. These presentations can be difficult to manage and often pose significant challenges for both the provider and the patient. This book reviews the most common psychiatric disorders and provides succinct management recommendations.

Contents: Preface; 1. General approach; 2. Management of agitation and violence; 3. Suicide assessments; 4. Managing substance abuse; 5. The psychotic patient; 6. The delirious patient; 7. The anxious patient; 8. Mood disorders; 9. Personality disorders; 10. Geriatric psychiatry; 11. Medicolegal and risk management; 12. Pediatric psychiatry; 13. Emergency department evaluation of intellectual and developmental disabilities; 14. Eating disorders; 15. Chronic pain; 16. Death, dying and grief; 17. Pregnancy and women’s issues; 18. Multicultural issues and safety.

2013 234 x 156 mm 318pp 978-0-521-87926-2 Hardback

The Burdens of Mental Disorders

£65.00

For all formats available, see

www.cambridge.org/9780521879262

Universitat Pompeu Fabra, Barcelona

Somnath Chatterji World Health Organization, Geneva

and Yanling He Shanghai Mental Health Center, Shanghai

This volume uses the findings of the WHO Mental Health surveys, which included more than 120,000 people from 24 countries, to present a comprehensive portrait of the burden of mental disorders. Considering both the individual and societal costs, this volume is valuable for anyone involved in mental health policy making.

Contents: Acknowledgements; Part I. Introduction: 1. Burdens of mental disorders: the approach of the World Mental Health (WMH) surveys; 2. Methods of the World Mental Health surveys; Part II. Mental Disorders and Personal Disadvantages: 3. Parent psychopathology and offspring mental disorders; 4. Associations between mental disorders and early termination of education; 5. Mental disorders, marriage and divorce; 6. Premarital mental disorders and risk for marital violence; 7. Earlyonset mental disorders and their links to chronic physical conditions in adulthood; Part III. Mental Disorders and Productivity Losses: 8. Association between serious mental illness and personal earnings; 9. Early-onset mental disorders and adult household income; 10. Family burden associated with mental and physical disorders; Part IV. Disability and Perceived Health Associated with Common Mental and Physical Disorders: 11. Days totally out of role associated with common mental and physical disorders; 12. Partial disability associated with common mental and physical disorders; 13. Disorder-specific disability and treatment of common mental and physical disorders; 14. Disability

For regular email alerts visit www.cambridge.org/alerts

14 associated with common mental and physical disorders; 15. Perceived health associated with common mental and physical disorders; 16. Decomposing the total associations of common mental and physical disorders with perceived health; Part V. Implications and Future Directions: 17. The burden of mental disorders in the Global Burden of Disease 2010 study and the World Mental Health surveys: similarities, differences and implications for mental health research; 18. The burdens of mental disorders: implications for policy; 19. Conclusions and future directions; Appendices; Index.

2013 246 x 189 mm 330pp 17 b/w illus. 107 tables 978-1-107-01928-7 Hardback

£75.00

For all formats available, see

www.cambridge.org/9781107019287

Suicide Global Perspectives from the WHO World Mental Health Surveys Matthew K. Nock Harvard University, Massachusetts

Guilherme Borges National Institute of Psychiatry, Mexico

and Yutaka Ono Keio University, Tokyo

Suicide is a serious public health problem worldwide, accounting for more deaths annually than all forms of war and interpersonal violence combined.

This book presents the results of the largest, most representative study of suicidal behaviors conducted to date, providing valuable information for anyone seeking to understand suicidal behavior.

Contents: Acknowledgements; Part I. Introduction: 1. Global perspectives on suicidal behavior; 2. The epidemiology of suicide and suicidal behavior; 3. Methods of the World Mental Health Surveys; Part II. Prevalence and Course of Suicidal Behavior: 4. Prevalence, onset, and transitions among suicidal behaviors; 5. Persistence of suicidal behaviors over time; Part III. Lifetime Risk Factors for Suicidal Behavior:

6. Sociodemographic risk factors for suicidal behavior: results from the WHO World Mental Health Surveys; 7. Parental psychopathology and the risk of suicidal behavior; 8. Childhood adversities as risk factors for onset and persistence of suicidal behavior; 9. Traumatic events and suicidal behavior; 10. Mental disorders and comorbidity: results from the WHO World Mental Health Surveys; 11. Chronic physical conditions and the onset of suicidal behavior; 12. Integrative models of suicidal behavior; Part IV. 12-Month Risk Factors and Treatment: 13. Prevalence and identification of groups at risk for 12-month suicidal behavior in the WHO World Mental Health Surveys; 14. Treatment of suicidal persons around the world; Part V. Conclusions and Future Directions: 15. Research, clinical, and policy implications of the World Mental Health Surveys findings on suicidal behavior; 16. Conclusions and future directions; Index.

‘The book represents an unprecedented opportunity to understand and prevent suicidal behavior based on a large and representative sample … It is unique in its extensive, comprehensive, and detailed tables of data …’

Doody’s Notes 2012 254 x 178 mm 401pp 17 b/w illus. 3 colour illus. 50 tables 978-0-521-76500-8 Hardback £80.00 For all formats available, see

www.cambridge.org/9780521765008

15 Behavioral Emergencies for the Emergency Physician

Clinical Handbook for the Management of Mood Disorders

Edited by Leslie S. Zun

Edited by J. John Mann

Department of Emergency Medicine, Mt Sinai Hospital, Chicago

Columbia University, New York

Edited in association with Lara G. Chepenik Yale University School of Medicine

and Mary Nan S. Mallory University of Louisville, School of Medicine

This comprehensive book covers all aspects of psychiatric emergencies, providing the expertise emergency physicians need to comfortably manage these patients, even when specialized psychiatric back-up is lacking.

Relevant pharmacology, management options, potential dilemmas in special populations and challenging diagnoses such as malingering, factitious and personality disorders are discussed.

Contents: Part I. General Considerations for Psychiatric Care in the Emergency Department; Part II. Evaluation of the Psychiatric Patient; Part III. Psychiatric Illnesses; Part IV. Treatment of the Psychiatric Patient; Part V. Special Populations; Part VI. Administration of Psychiatric Care.

2013 276 x 219 mm 414pp 13 b/w illus.

978-1-107-01848-8 Paperback £55.00 For all formats available, see

www.cambridge.org/9781107018488

Edited in association with Patrick J. McGrath Columbia University, New York

and Steven P. Roose Columbia University, New York

This book equips clinicians with the knowledge to refine their diagnostic skills and implement treatment plans based on the most up-to-date evidence on interventions that work. Covering the widest range of treatments and techniques, this book provides clear guidance for the management of all types and subtypes of minor and major depression.

Contents: Preface; Part I. Introduction: 1. Models of depression; 2. Diagnosis of mood disorders; 3. Dysthymia and chronic depression; Part II. Medical Management: 4. Management of adult major depressive disorder; 5. Atypical depression; 6. Psychotic depression; 7. Pharmacologic and somatic treatments for bipolar depression; 8. Medication treatment of mania: acute and preventive; 9. Treatment of mood disorders in later life; 10. Chronic depression; 11. Pediatric depression; 12. Therapeutics of pediatric bipolar disorder; 13. Depression in the context of physical illness; 14. Mood disorders in the context of borderline personality disorder; 15. Depression in the context of pregnancy; 16. Depression and the menstrual cycle; 17. Depression in the context of alcoholism and other substance use disorders; 18. Complementary and alternative treatments for mood disorders; Part III. Psychotherapies for Mood Disorders: 19. Cognitive behavior therapy; 20. Interpersonal therapy; 21. Dialectical behavioral therapy for mood disorders; 22. The psychodynamic treatment of mood disorders; 23. Combining medication and psychotherapy in the treatment of depression; Part IV. Specific Modalities of Treatment: 24. Electroconvulsive therapy;

eBooks available at www.cambridge.org/ebookstore

16 25. Transcranial magnetic stimulation and deep brain stimulation; 26. Chronotherapeutics: light therapy, wake therapy, and melatonin; 27. Ketamine in treatment-resistant depression; Part V. The Promise of Biomarkers and Response Prediction: 28. Brain imaging; 29. Pharmacogenetics and mood disorders; 30. Electrophysiological predictors of clinical response to antidepressants; Part VI. Future Directions: 31. Future directions; Index.

2013 246 x 189 mm 426pp 26 b/w illus. 20 tables 978-1-107-02463-2 Hardback

£65.00

For all formats available, see

www.cambridge.org/9781107024632

The Autism Spectrum Scientific Foundations and Treatment Edited by Mark Reber Drexel University, Philadelphia

Written for the wide range of physicians and professionals who treat children and adults with autism spectrum disorders, this book reviews the scientific research on the nature and causes of autism, outlines best treatment practices with children and describes a comprehensive assessment and treatment approach for adults.

Contents: Part I. What We Know about Autism and How We Know It: 1. Nosology: definitions and diagnoses; 2. Epidemiology; 3. Phenomenology: the neuropsychology of autism; 4. Pathophysiology: the neuroscience of autism; 5. Etiology: syndromic autism; 6. Etiology: essential autism; Part II. Assessing and Treating Children with Autism: 7. Clinical diagnostic evaluation; 8. Special education; 9. Habilitation therapies (including speechlanguage and occupational therapies and assistive technology); 10. Behavioral therapies; 11. Pharmacotherapy and nutritional therapies; Part III. Assessing and Treating Adults with Autism: 12. Clinical assessment of adults; 13. Treatment planning for adults.

2012 234 x 156 mm 346pp 978-0-521-11687-9 Hardback

£58.00

For all formats available, see

www.cambridge.org/9780521116879

Brain Stimulation in Psychiatry ECT, DBS, TMS and Other Modalities Charles H. Kellner Mount Sinai School of Medicine, New York

The field of brain stimulation is advancing at rapid pace with a growing number of techniques now approved for the treatment of psychiatric illness.

This text acts both as a concise, quick reference for experienced practitioners and a guidebook for residents learning about clinical brain stimulation techniques.

Contents: 1. Introduction; 2. Electroconvulsive therapy (ECT): basic concepts; 3. Electroconvulsive therapy (ECT): patient selection and preparation; 4. Electroconvulsive therapy (ECT): technique; 5. Electroconvulsive therapy (ECT): treatment course; 6. Electroconvulsive therapy (ECT): common adverse effects; 7. Electroconvulsive therapy (ECT): the ECT service; 8. Electroconvulsive therapy (ECT): special issues; 9. Deep brain stimulation (DBS); 10. Transcranial magnetic stimulation (rTMS); 11. Magnetic seizure therapy (MST); 12. Vagus nerve stimulation (VNS); 13. Transcranial direct current stimulation (TDCS); Index.

‘… up to date, practical and userfriendly … highly recommended …’

Journal of Clinical Psychiatry 2012 234 x 156 mm 158pp 16 b/w illus.

978-0-521-17255-4 Paperback £36.99 For all formats available, see

www.cambridge.org/9780521172554

17 Marijuana and Madness Second edition Edited by David Castle University of Melbourne

Robin M. Murray Institute of Psychiatry

and Deepak Cyril D’Souza Yale University, Connecticut

The second edition of this critically acclaimed and award-winning text provides a comprehensive overview of the psychiatry and neuroscience of cannabis. It has been extensively updated and expanded with 10 new chapters to incorporate major new research findings. It is suitable for all members of the mental health team.

Contents: Foreword; Preface; Part I. Pharmacology of Cannabis and the Endocannabinoid System: 1. The cannabinoid system from the point of view of a chemist; 2. The function of the endocannabinoid system; 3. How cannabis works in the brain; Part II. The Changing Face of Cannabis: 4. The epidemiology of cannabis use: an international perspective; 5. Is cannabis becoming more potent?; 6. Health policy and cannabis; Part III. Cannabis and the Brain: 7. Cannabis, endocannabinoids and neurodevelopment; 8. The impact of pubertal exposure to cannabis on the brain: a focus on animal studies; 9. Cannabis and cognition: short and long-term effects; 10. Does cannabis cause lasting brain damage?; Part IV. Cannabis, Anxiety and Mood: 11. Acute and subacute psychiatric effects of cannabis; 12. The association between cannabis use and depression; 13. Cannabis and bipolar disorder; Part V. Cannabis and Psychosis: 14. Cannabis and psychosis proneness; 15. Genetic factors that moderate the psychomimetic effects

of cannabis; 16. Cannabis causes positive, negative, cognitive symptoms and produces impairments in electrophysiological indices of information processing; 17. The neural basis for the acute effects of cannabis on learning and psychosis; Part VI. Cannabinoids and Schizophrenia: Aetiopathology and Treatment Implications: 18. Does cannabis cause schizophrenia?; 19. Postmortem studies of the brain cannabinoid system in schizophrenia; 20. The endogenous cannabinoid system in schizophrenia; 21. The endocannabinoid system as a target for pharmacotherapy of schizophrenia; Part VII. Cannabis and its Impact on Schizophrenia: 22. Acute effects of cannabis in established schizophrenia; 23. Cannabis and the long-term course of schizophrenia; 24. Motives that maintain cannabis use in schizophrenia; 25. Treatment interventions for cannabis abuse in people with psychosis; Part VIII. Integration: 26. Cannabis and mental illness: an integration; Index.

‘The editors and publishers of this book have responded to a need for clear, research-based information on a topic of great current concern. They have done an excellent job.’

American Journal of Psychiatry 2011 246 x 189 mm 252pp 29 b/w illus. 8 tables 978-1-107-00021-6 Hardback

£63.00

For all formats available, see

www.cambridge.org/9781107000216

For regular email alerts visit www.cambridge.org/alerts

18 Essential Evidence-Based Psychopharmacology Second edition Edited by Dan Stein University of Cape Town

Bernard Lerer Hadassah-Hebrew Medical Centre

and Stephen M. Stahl University of California, San Diego

Presents up-to-date, comprehensive reviews of the psychopharmacological evidence-base for each of the major psychiatric disorders. The content has been fully updated and includes new chapters on personality disorders, nicotine and alcohol dependence.

Essential for all practising and trainee clinicians, in a mental health setting or a less specialised environment.

Contents: Preface; Foreword; 1. Evidencebased pharmacotherapy of attention deficit hyperactivity disorder; 2. Evidencebased pharmacotherapy of schizophrenia; 3. Evidence-based pharmacotherapy of bipolar disorder; 4. Evidence-based pharmacotherapy of major depressive disorder; 5. Evidencebased pharmacotherapy of panic disorder; 6. Evidence-based pharmacotherapy of social anxiety disorder; 7. Evidence-based pharmacotherapy of generalised anxiety disorder; 8. Evidence-based pharmacotherapy of obsessive-compulsive disorder; 9. Evidencebased pharmacotherapy of posttraumatic stress disorder; 10. Evidence-based pharmacotherapy of eating disorders; 11. Evidence-based pharmacotherapy of nicotine and alcohol dependence;

12. Evidence-based pharmacotherapy of illicit substance use disorders; 13. Evidence-based pharmacotherapy of Alzheimer’s disease; 14. Evidence-based pharmacotherapy of personality disorders; Index.

‘Essential Evidence-Based Psychopharmacology would be a very good text for psychiatrists in practice and especially those who have recently graduated from a residency training program and are beginning their practice.’

David L. Dunner, Journal of Clinical Psychiatry 2012 234 x 156 mm 334pp 3 b/w illus.

978-1-107-00795-6 Hardback £95.00 978-1-107-40010-8 Paperback £48.00 For all formats available, see

www.cambridge.org/9781107007956

19 Principles of Psychiatric Genetics Edited by John I. Nurnberger, Jr Indiana University School of Medicine

and Wade Berrettini University of Pennsylvania School of Medicine

Psychiatric genetics is a rapidly advancing field, elucidating the varied roles of specific genes in brain development and dysregulation.

This up-to-date compilation features 22 disorder-based chapters, with additional focus on key topics including epidemiology and ethics. An indispensable reference for psychiatrists, neurologists, psychologists and anyone involved in psychiatric genetic studies.

personality disorders; 22. Ethical issues in behavioral genetics; 23. Genetics of Tourette syndrome and related disorders; 24. Endophenotypes; 25. Developmental disorders; Index.

‘A magnificent and timely contribution.

I especially enjoyed Dan Geschwind’s chapter on autism.’

Solomon Snyder, University Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry, The Johns Hopkins University School of Medicine 2012 246 x 189 mm 414pp 58 b/w illus. 21 colour illus.

978-0-521-89649-8 Hardback

£90.00

For all formats available, see

www.cambridge.org/9780521896498

Contents: Preface; 1. Contribution of genetic epidemiology to our understanding of psychiatric disorders; 2. A basic overview of contemporary human genetic analysis strategies; 3. In silico analysis strategies and resources for psychiatric genetics research; 4. Gene expression studies in psychiatric disorders; 5. Pharmacogenetics in psychiatry; 6. Functional validation of candidate genetic susceptibility factors for major mental illnesses: from protein chemistry, cell biology, animal study, to human brain imaging; 7. Epigenetic mechanisms in drug addiction and depression; 8. Panic disorder; 9. The genetics of phobic disorders and generalized anxiety disorder; 10. Genetic contributions to obsessivecompulsive disorder (OCD) and OCD-related disorders; 11. Post-traumatic stress disorder; 12. Antisocial behavior: gene environment interplay; 13. Learning disabilities; 14. Autism and autism spectrum disorders; 15. Genetics of major depression; 16. The genetics of anorexia and bulimia nervosa; 17. Genetics and common human obesity; 18. Alcoholism; 19. Nicotine dependence; 20. Genetics of stimulant dependence; 21. Genetics of

Visit our website at www.cambridge.org/knowledge

20 Resilience The Science of Mastering Life’s Greatest Challenges Steven M. Southwick Yale University School of Medicine

and Dennis S. Charney Mount Sinai School of Medicine, New York

Many of us are struck by major trauma sometime in our lives. This inspiring book identifies ten key ways to weather and bounce back from stress and trauma.

Incorporating the latest scientific research and interviews with trauma survivors, it provides a practical guide to building emotional, mental and physical resilience.

Contents: Preface; 1. What is resilience?; 2. Optimism: belief in a brighter future; 3. Facing fear: an adaptive response; 4. Moral compass, ethics and altruism: doing what is right; 5. Religion and spirituality: drawing on faith; 6. Social support: learning the tap code; 7. Training: physical fitness and strengthening; 8. Brain fitness: challenge your mind and heart; 9. Role models: providing the road map; 10. Cognitive and emotional flexibility; 11. Meaning, purpose and growth; 12. The practice of resilience; Index.

‘[The authors] have written a crisp, user-friendly guide to the latest scientific research on resilience. With a light touch, they illuminate what seems to be every major study in the field over the last 20 years. ’ The Washington Independent Review of Books 2012 234 x 156 mm 240pp 978-0-521-19563-8 Paperback £15.99 For all formats available, see

www.cambridge.org/9780521195638

Trauma and Forgiveness Consequences and Communities C. Fred Alford University of Maryland, College Park

C. Fred Alford argues that the traumatized are generally capable of representing their experience. Using evidence from the testimonies of Holocaust survivors, as well as the victims of ‘ordinary’ trauma, he shows that forgiveness is generally a way of avoiding the hurt and pain of coming to terms with trauma.

Contents: 1. Introduction: trauma and forgiveness; 2. Is the Holocaust traumatic?; 3. Winnicott and trauma; 4. Melanie Klein and forgiveness: theory; 5. Melanie Klein and forgiveness: practice; 6. Winnicott: forgiveness and transitional experience; 7. Jean Améry: resentment, loneliness, and aging; 8. Conclusion: trauma as knowledge.

‘This book is a gem – a profound, eloquent, and memorable meditation on the ravages of trauma and the vicissitudes of forgiveness.’

Marshall Alcorn, The George Washington University 2014 228 x 152 mm 225pp 978-1-107-04340-4 Hardback

£60.00

For all formats available, see

www.cambridge.org/9781107043404

21 The Psychology of Fatigue

Power, Powerlessness and Addiction

Work, Effort and Control Robert Hockey

Jim Orford

University of Sheffield

Jim Orford argues that power and powerlessness have been neglected in addiction studies. He covers the disempowering nature of addiction, effects on family and others, social resources and vulnerability, studies of the legal and illegal supply, and theories of treatment and change.

The first systematic treatment of fatigue for over sixty years, radically reconfiguring the landscape of the subject. By casting fatigue in the role of an emotion, this book provides a new framework for thinking about it as a mechanism for managing competing activities and discouraging overcommitment to unrewarding goals.

Contents: 1. The problem of fatigue; 2. Changing experiences of fatigue: the social-historical context; 3. The work-fatigue hypothesis; 4. Stress, coping and fatigue; 5. Effort, strain and fatigue; 6. A motivation control theory of fatigue; 7. Extensions and limitations: energy, physical work and sleep; 8. The psychopathology of fatigue; 9. An agenda for fatigue: research and application.

‘Bob Hockey has produced an outstanding book containing easily the best theoretical account of fatigue ever produced. This book (which also provides a fascinating historical account) is destined to become an ‘instant classic’.’

Michael W. Eysenck, Roehampton University 2013 228 x 152 mm 284pp 10 b/w illus. 3 tables 978-0-521-76265-6 Hardback

£60.00

For all formats available, see

www.cambridge.org/9780521762656

University of Birmingham

Contents: 1. Powerful connections: three examples of addiction; 2. How addiction erodes free agency; 3. Addiction subordinates the interests of family members and friends; 4. Inequality in the power to resist addiction; 5. Power and powerlessness in the addiction supply industries; 6. Reasserting control and power in the process of change and treatment; 7. Facing up to the power of addiction and those who benefit from it.

‘This book brings together Jim Orford’s vast knowledge of addiction research and theory and, using the unifying concept of power, it examines the multi-layered nature of how we are, at several levels, disempowered by our involvement with addictive consumptions.’

Peter J. Adams, Centre for Addiction Research, University of Auckland, and author of Fragmented Intimacy: Addiction in a Social World 2013 228 x 152 mm 273pp 978-1-107-03476-1 Hardback £50.00 978-1-107-61009-5 Paperback £18.99 For all formats available, see

www.cambridge.org/9781107034761

eBooks available at www.cambridge.org/ebookstore

22 Neuropsychiatric and Cognitive Changes in Parkinson’s Disease and Related Movement Disorders Diagnosis and Management Edited by Dag Aarsland Stavanger University Hospital, Stavanger

Jeffrey Cummings Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

Daniel Weintraub University of Pennsylvania

and K. Ray Chaudhuri King’s College Hospital, London

Psychiatric and cognitive changes are common in patients with Parkinson’s disease but these symptoms are often under-diagnosed and under-treated.

Written by experts in the field, with a consistent focus on relevant clinical knowledge, the book provides a comprehensive overview, including all major behavioral changes associated with Parkinson’s disease.

Contents: Preface; Part I. General Aspects: Part II. Diagnosis and Biomarkers: Part III. Specific Neuropsychiatric Disorders: Part IV. Management: Part V. Other Issues.

2013 246 x 189 mm 307pp 25 b/w illus. 5 colour illus. 51 tables 978-1-107-03922-3 Hardback £70.00 For all formats available, see

www.cambridge.org/9781107039223

A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs Second edition D. G. Cunningham Owens University of Edinburgh

Provides a comprehensive, literaturebased but clinically-oriented overview of the pervasive neurological adverse effects that frequently affect those receiving antipsychotic (and pharmacologically related) drugs, giving valuable information to the wide range of healthcare professionals who prescribe and monitor these extensively utilised therapeutic agents.

Contents: Preface; Part I. Setting the Scene: 1. The origins of psychopharma; 2. Some preliminaries; Part II. The Syndromes: 3. Acute dystonias; 4. Parkinsonism; 5. Akathisia; 6. Tardive dyskinesia; Part III. Particular Issues: 7. Tardive and chronic dystonia; 8. Special populations; Part IV. Assessment: 9. The clinical examination; 10. An overview of some standardised recording instruments; Part V. Matters Arising: 11. Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia?; 12. And finally … the salutary tale of ‘atypicality’; References; Index.

2014 246 x 189 mm 424pp 70 b/w illus. 72 tables 978-1-107-02286-7 Hardback Publication April 2014

£75.00

For all formats available, see

www.cambridge.org/9781107022867

Journals in Mental Health from Cambridge

For a full list of our journals in Psychology and Psychotherapy visit:

journals.cambridge.org/psych

S i g n u p to

Cambridge Alerts

for regular updates and to receive 15% off your next online purchase www.cambridge.org/alerts

Follow us on Twitter @cambUP_medicine

EBooks For individuals: You can find information about ebook availability on each book’s webpage under Other available formats For institutions: Cambridge publications are also available for institutional purchase as online collections and packages.

Visit: www.universitypublishingonline.org

29096